Abiomed (ABMD) Tops Q3 EPS by 3c; Narrows Margin Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
ABIOMED (ABMD) PT Lowered to $385 at Raymond James
February 1, 2019 7:38 AM ESTRaymond James analyst Jayson Bedford lowered the price target on ABIOMED (NASDAQ: ABMD) to $385.00 (from $400.00) while maintaining a Outperform rating.
... More


